Major considerations for facilities where any pharmaceuticals are manufactured or processed (including blood that will be used for transfusion) include space, organization, and cleanliness. CFR Title 21 part 211 subpart C discusses areas that should be separate or in some way defined to prevent contamination and mix ups.
Developing a logical workflow will also help with error reduction.